RxDoctor Payments Data

Patricia Schmidt

Family · East Greenwich, RINPI 1851314637

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,739 of the $7,114 with a category attached, or 66.6%. It is spread thinly across 17 manufacturers, the largest accounting for just 22.5%. Reporting peaked in 2022 at $3,320 and has fallen 77.1% since, to $759 in 2025. Among family clinicians in RI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,114in general payments, 2019–2025

Across 138 payments — averaging $51.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Almirall LLC$2K
  • EPI Health, LLC$914
  • Pfizer$821
  • Incyte Corporation$776
  • AbbVie$667
  • Regeneron Healthcare Solutions, Inc.$420
  • plus $2K from 11 others

What the payments were for

  • Consulting fees$2,20031%
  • Speaking & faculty fees$751%
  • Food & beverage$4,73967%
  • Education$1001%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,114 in reported general payments places this provider in the 95th percentile of 457 family providers in Rhode Island.

See all family providers in Rhode Island

Medicare billing

Part B allowed, 2024
$127,630
Medicare patients
562
Services billed
2,033

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cosentyx Sensoready (2 Pens)Secukinumab11$79,021
Clobetasol Propionate83$4,178
Ketoconazole137$2,333
Metronidazole39$1,983
Tretinoin29$1,849
Triamcinolone Acetonide149$1,367
Fluorouracil22$1,339
ValacyclovirValacyclovir Hcl32$1,260
Betamethasone Dipropionate23$748
Minoxidil57$690
Doxycycline Hyclate36$565
Betamethasone Valerate20$521
Econazole Nitrate14$415
Nystatin21$255
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc15$251

Paid to pharmacies, not to this prescriber.

Other family in East Greenwich

See the full list for Rhode Island

Where these figures come from

Is this you, or does something look wrong? →